The company's
exclusive focus is the
successful development
of technologies for the groundbreaking treatment of central nervous system traumatic injuries.
Our goal is
to develop
and commercialize
nervous
system
injury corrective therapeutics. Our success will establish our company as a premier firm in the
field of biomarkers monitoring.
Site Under Construction